Anders Eklund Selected Research

Sarcoidosis (Schaumann Disease)

1/2022	Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
1/2022	Pulmonary and blood dendritic cells from sarcoidosis patients more potently induce IFNγ-producing Th1 cells compared with monocytes.
1/2022	Phenotypic and HLA-DRB1 allele characterization of Swedish cardiac sarcoidosis patients.
11/2021	Risk of acute myocardial infarction in sarcoidosis: A population-based cohort study from Sweden.
10/2021	HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis.
4/2021	Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids.
1/2021	Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data.
1/2021	Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis.
1/2021	Monocytes in sarcoidosis are potent tumour necrosis factor producers and predict disease outcome.
1/2020	High-intensity resistance training in newly diagnosed sarcoidosis- an exploratory study of effects on lung function, muscle strength, fatigue, dyspnea, health-related quality of life and lung immune cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Eklund Research Topics

Disease

51	Sarcoidosis (Schaumann Disease) 01/2022 - 09/2002
13	Inflammation (Inflammations) 01/2020 - 09/2002
7	Pulmonary Sarcoidosis 12/2018 - 11/2010
6	Hydrocephalus (Hydrocephaly) 01/2022 - 12/2004
6	Granuloma 01/2022 - 12/2008
6	Rheumatoid Arthritis 01/2020 - 01/2006
6	Asthma (Bronchial Asthma) 01/2020 - 11/2007
3	Lung Diseases (Lung Disease) 07/2018 - 11/2007
2	Infections 01/2021 - 01/2020
2	Necrosis 01/2021 - 07/2012
2	Normal Pressure Hydrocephalus 01/2020 - 01/2008
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2019 - 02/2015
1	Atrioventricular Block 01/2022
1	Ventricular Tachycardia 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Disease Progression 01/2022
1	Hypercalcemia (Milk Alkali Syndrome) 10/2021
1	Type 2 Diabetes Mellitus (MODY) 04/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Ocular Hypertension (Glaucoma, Suspect) 10/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Fatigue 01/2020
1	Pneumonia (Pneumonitis) 07/2018
1	Tertiary Lymphoid Structures 01/2018
1	Epilepsy (Aura) 01/2018
1	Amyloid Plaque 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2004
11	AntigensIBA 01/2022 - 09/2002
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2004
8	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 11/2007
8	CytokinesIBA 01/2021 - 01/2006
6	Peptides (Polypeptides)IBA 01/2020 - 11/2007
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 11/2006
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 03/2004
5	AutoantigensIBA 01/2018 - 01/2006
4	AntibodiesIBA 01/2020 - 01/2006
4	Immunoglobulin G (IgG)IBA 05/2019 - 03/2015
4	Messenger RNA (mRNA)IBA 01/2015 - 09/2010
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 04/2021 - 09/2015
3	Anti-Citrullinated Protein AntibodiesIBA 01/2020 - 01/2014
3	VimentinIBA 01/2018 - 11/2007
3	ProteomeIBA 03/2016 - 03/2013
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2010 - 01/2006
3	Nerve Growth Factors (Neurotrophins)IBA 11/2010 - 01/2006
3	Nerve Growth Factor (NGF)IBA 11/2010 - 01/2006
3	HLA-DR Antigens (HLA-DR)IBA 12/2009 - 01/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 10/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021 - 01/2021
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 12/2019 - 02/2015
2	LipidsIBA 12/2018 - 01/2012
2	Amino Acids FDA Link 01/2017 - 08/2015
2	Interleukin-2 (IL2)IBA 01/2016 - 07/2012
2	AllergensIBA 01/2014 - 01/2012
2	Peroxidase (Myeloperoxidase)IBA 07/2012 - 12/2008
2	CatalaseIBA 07/2012 - 12/2008
2	InterferonsIBA 07/2012 - 11/2010
2	3-iodo-4-azido-N-hexadecylsalicylamideIBA 04/2007 - 12/2004
1	HLA-DRB1*04 antigenIBA 10/2021
1	CreatinineIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Azathioprine (Imuran)FDA LinkGeneric 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Infliximab (Remicade)FDA Link 01/2021
1	N 30IBA 10/2020
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2020
1	montelukast (Singulair)FDA Link 01/2020
1	LeukotrienesIBA 01/2020
1	Glycerol (Glycerine)FDA LinkGeneric 12/2019
1	EicosanoidsIBA 12/2018
1	EndocannabinoidsIBA 12/2018
1	AcidsIBA 12/2018
1	EnzymesIBA 12/2018
1	Epoxide HydrolasesIBA 12/2018
1	SphingolipidsIBA 12/2018
1	Polysaccharides (Glycans)IBA 07/2018
1	Immunoglobulin IsotypesIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	MitogensIBA 01/2018
1	Granzymes (Granzyme)IBA 01/2018
1	PerforinIBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	Vitamin D-Binding ProteinIBA 04/2017
1	leukotriene A4 hydrolaseIBA 04/2017
1	HLA-DR alpha-ChainsIBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	tau Proteins (tau Protein)IBA 01/2017
1	Antirheumatic Agents (DMARD)IBA 11/2016
1	16S Ribosomal RNAIBA 11/2016
1	Pyruvic Acid (Pyruvate)IBA 03/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Interleukin-22 (IL-22)IBA 01/2016

Therapy/Procedure

3	Therapeutics 12/2019 - 02/2015
1	Cerebrospinal Fluid Shunts 01/2022
1	Carotid Endarterectomy 01/2021
1	Resistance Training 01/2020
1	Ambulatory Care (Outpatient Care) 12/2016